Top 20 EGFR+ NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating EGFR Mutations in NSCLC. An Editor …

SHI Ou, X Le, M Nagasaka… - Lung Cancer: Targets …, 2024 - Taylor & Francis
The year 2024 is the 20th anniversary of the discovery of activating epidermal growth factor
receptor (EGFR) mutations in non-small cell lung cancer (NSCLC). Since then, tremendous …

Finding One Treatment for All Advanced EGFR-positive NSCLC—An Infinite Task

EM Urbanska, JB Sørensen, E Santoni-Rugiu - Journal of Thoracic Oncology, 2024 - jto.org
To the Editor: Inspired by the two interesting papers by Lim et al. 1 and by Chen et al. 2
recently published in the Journal of Thoracic Oncology, we would like to share additional …